| Literature DB >> 33986426 |
Li Zhao1, Xiaoshi Yang1, Fengzhi Yang1, Guoyuan Sui2, Yi Sui3, Bing Xu3, Bo Qu4.
Abstract
Patients with stroke are likely to experience impaired health-related quality of life (QOL), especially during the COVID-19 pandemic. This study aimed to evaluate the QOL of Chinese patients with stroke during the pandemic and explore the associated variables. A matched-pair, multicenter survey was conducted before and during the COVID-19 pandemic. Questionnaires including the 36-item Short-Form Health Survey (SF-36), the Activities of Daily Living (ADL) scale, and the Questionnaire about the Process of Recovery (QPR) were used. A total of 172 matched pairs (344 patients) were recruited in this study. Hierarchical multiple regression analysis was performed to analyze variables associated with QOL. Physical and mental component scores (PCS and MCS) were higher among the stroke patients during the pandemic (44.20 ± 18.92 and 54.24 ± 19.08) than before the pandemic (37.98 ± 14.52 and 43.50 ± 20.94). Pandemic stress, demographic and clinical characteristics were negative variables associated with PCS and MCS. QPR was positively associated with PCS and MCS. The QOL of Chinese stroke patients was higher during than before the COVID-19 pandemic. Pandemic stress aggravated stroke patients' QOL, while personal recovery could alleviate the detrimental effect of pandemic stress on QOL for stroke patients.Entities:
Year: 2021 PMID: 33986426 PMCID: PMC8119409 DOI: 10.1038/s41598-021-89746-8
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Comparisons of PCS and MCS by demographic and clinical characteristics of patients with stroke (n = 344).
| Variable | Before the pandemic ( | During the pandemic( | Total( | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ≤ 60 | 87 (50.58) | 41.66 ± 16.04** | 0.001 | 48.78 ± 20.34** | 0.001 | 50 (29.07) | 47.09 ± 17.84 | 0.200 | 59.56 ± 19.45** | 0.019 | 137 (39.83) | 43.64 ± 16.86* | 0.021 | 52.71 ± 20.62** | 0.005 |
| > 60 | 85 (49.42) | 34.22 ± 11.72 | 38.10 ± 20.26 | 122 (70.93) | 43.01 ± 19.29 | 52.06 ± 18.58 | 207 (60.14) | 39.40 ± 17.12 | 46.33 ± 20.43 | ||||||
| Male | 114 (66.28) | 38.42 ± 14.51 | 0.579 | 43.96 ± 21.81 | 0.689 | 109 (63.37) | 43.45 ± 19.18 | 0.500 | 54.06 ± 19.49 | 0.872 | 223 (64.83) | 40.88 ± 17.10 | 0.760 | 48.90 ± 21.28 | 0.975 |
| Female | 58 (33.73) | 37.12 ± 14.61 | 42.60 ± 19.25 | 63 (36.63) | 45.48 ± 18.54 | 54.55 ± 18.52 | 121 (35.14) | 41.47 ± 17.22 | 48.83 ± 19.73 | ||||||
| Married | 160 (93.02) | 37.44 ± 14.08 | 0.070 | 42.80 ± 20.95 | 0.110 | 154 (89.52) | 44.25 ± 19.29 | 0.912 | 54.56 ± 19.46 | 0.525 | 314 (91.28) | 40.78 ± 17.16 | 0.275 | 48.57 ± 21.04 | 0.381 |
| Other | 12 (6.98) | 45.29 ± 18.61 | 52.81 ± 19.26 | 18 (10.47) | 43.73 ± 15.78 | 51.53 ± 15.81 | 30 (8.73) | 44.35 ± 16.67 | 52.04 ± 16.96 | ||||||
| High school or above | 102 (59.30) | 40.64 ± 14.49** | 0.003 | 46.41 ± 21.81** | 0.024 | 79 (45.93) | 47.34 ± 19.67* | 0.044 | 54.61 ± 18.13 | 0.815 | 181 (52.62) | 43.57 ± 17.22** | 0.005 | 49.99 ± 20.64 | 0.293 |
| Junior school or under | 70 (40.70) | 34.11 ± 13.74 | 39.27 ± 18.96 | 93 (54.07) | 41.52 ± 17.93 | 53.93 ± 19.96 | 163 (47.38) | 38.34 ± 16.63 | 47.63 ± 20.79 | ||||||
| ≤ 3000 | 58 (33.72) | 33.61 ± 15.36 | 0.018 | 35.53 ± 17.05 | 0.001 | 72 (41.86) | 44.58 ± 19.28 | 0.451 | 53.01 ± 17.44 | 0.331 | 130 (37.79) | 39.69 ± 18.40 | 0.269 | 45.22 ± 19.29 | 0.029 |
| 3001–6000 | 76 (44.19) | 40.19 ± 14.34** | 46.58 ± 20.16** | 90 (52.33) | 44.71 ± 18.88 | 55.96 ± 20.75 | 166 (48.26) | 42.64 ± 17.06 | 51.66 ± 21.22* | ||||||
| > 6000 | 38 (22.09) | 40.21 ± 14.52* | 49.51 ± 23.40** | 10 (5.81) | 36.84 ± 16.64 | 47.64 ± 13.37 | 48 (13.95) | 39.51 ± 13.10 | 49.12 ± 21.59* | ||||||
| > 3 | 118 (68.60) | 38.99 ± 14.97 | 0.180 | 43.58 ± 21.16 | 0.940 | 118 (68.60) | 42.35 ± 15.74 | 0.105 | 53.51 ± 19.30 | 0.456 | 236 (68.60) | 40.67 ± 15.42 | 0.542 | 48.55 ± 20.81 | 0.669 |
| ≤ 2 | 54 (31.40) | 35.79 ± 13.33 | 43.32 ± 20.34 | 54 (31.40) | 48.24 ± 24.15 | 22.83 ± 18.69 | 108 (31.40) | 42.01 ± 20.40 | 49.58 ± 20.58 | ||||||
| Mild disability | 50 (29.07) | 51.48 ± 14.26** | 0.001 | 53.12 ± 19.73** | 0.001 | 68 (39.53) | 57.45 ± 19.66** | 0.001 | 56.73 ± 17.55 | 0.168 | 118 (34.30) | 54.92 ± 17.76** | 0.001 | 55.20 ± 18.50** | 0.001 |
| High disability | 122 (70.93) | 32.45 ± 10.46 | 39.56 ± 20.20 | 104 (60.47) | 35.53 ± 12.28 | 52.61 ± 19.95 | 226 (65.70) | 33.87 ± 11.41 | 45.57 ± 21.07 | ||||||
| Intracerebral hemorrhage | 50 (29.07) | 36.36 ± 15.24 | 42.99 ± 20.44 | 39 (22.67) | 35.26 ± 16.74 | 48.40 ± 18.85 | 89 (25.87) | 35.88 ± 15.83 | 45.37 ± 19.83 | 0.064 | |||||
| Cerebral infarction | 122 (70.93) | 38.65 ± 14.22 | 0.348 | 43.71 ± 21.22 | 0.840 | 133 (77.33) | 46.81 ± 18.77** | 0.001 | 55.95 ± 18.89** | 0.029 | 255 (74.13) | 42.91 ± 17.21** | 0.001 | 50.10 ± 20.91 | |
| Y | 163 (94.77) | 37.18 ± 14.24 | 0.002 | 43.03 ± 20.88 | 0.208 | 117 (68.02) | 39.19 ± 15.91 | 0.001 | 51.67 ± 17.77 | 0.009 | 280 (81.39) | 38.02 ± 14.97 | 0.001 | 46.64 ± 20.06 | 0.001 |
| N | 9 (5.23) | 52.51 ± 11.91** | 52.07 ± 21.36 | 55 (31.68) | 54.85 ± 20.47** | 59.72 ± 20.76** | 64 (18.60) | 54.52 ± 19.44** | 58.64 ± 20.84** | ||||||
| Y | 44 (25.59) | 33.23 ± 15.52 | 0.011 | 31.80 ± 17.58 | 0.001 | 47 (27.32) | 36.78 ± 17.11 | 0.001 | 52.24 ± 16.88 | 0.401 | 91 (36.45) | 35.06 ± 16.37 | 0.001 | 42.36 ± 19.97 | 0.001 |
| N | 128 (74.41) | 39.62 ± 13.84** | 47.52 ± 20.54** | 125 (72.67) | 46.98 ± 18.87** | 54.99 ± 19.87 | 253 (73.55) | 43.26 ± 16.90** | 51.22 ± 20.51** | ||||||
| Y | 6 (3.49) | 25.90 ± 5.54 | 0.038 | 22.42 ± 4.53 | 0.012 | 64 (37.21) | 42.02 ± 18.65 | 0.246 | 57.49 ± 20.34 | 0.086 | 70 (20.35) | 40.64 ± 18.45 | 0.805 | 54.49 ± 21.84** | 0.011 |
| N | 166 (96.51) | 38.42 ± 14.56** | 44.26 ± 20.90** | 108 (62.79) | 45.49 ± 19.04 | 52.32 ± 18.13 | 274 (79.65) | 41.20 ± 16.80 | 47.44 ± 20.21 | ||||||
*p < 0.05, **p < 0.01.
Figure 1Comparison of stroke patients’ QOL before and during the COVID-19 pandemic. The overall PCS, MCS and the PF, RP, GH, RE, SF, VT sub-scores were significantly higher during the pandemic than those before the pandemic.
Comparisons of PCS, MCS and QPR during the COVID-19 pandemic by thoughts about the pandemic (M ± SD, n = 172).
| Variable | Felt that the “impacts of the pandemic on daily life were high or very high” | Felt that the “risks of contracting COVID-19 were high or very high” | Felt that “worries about the pandemic were high or very high” | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 72 (41.86) | 100 (58.14) | 49 (28.49) | 123 (71.51) | 46 (26.74) | 126 (73.26) | ||||
| 40.41 ± 15.91 | 49.45 ± 21.46** | 0.003 | 38.07 ± 14.34 | 46.63 ± 19.99** | 0.002 | 38.75 ± 12.17 | 46.18 ± 20.52** | 0.004 | |
| PF | 26.35 ± 17.62 | 35.35 ± 23.69 | 0.056 | 19.49 ± 12.30 | 34.35 ± 22.38** | 0.001 | 24.13 ± 14.57 | 32.30 ± 22.26 | 0.080 |
| RP | 12.50 ± 8.98 | 28.13 ± 12.36** | 0.008 | 12.76 ± 7.06 | 21.54 ± 18.71 | 0.094 | 13.59 ± 9.68 | 21.03 ± 17.87 | 0.181 |
| BP | 69.78 ± 26.24 | 77.47 ± 26.76 | 0.062 | 65.99 ± 24.58 | 75.79 ± 27.03** | 0.029 | 65.22 ± 24.07 | 75.84 ± 27.07* | 0.015 |
| GH | 53.03 ± 12.71 | 56.85 ± 12.54 | 0.052 | 54.06 ± 13.04 | 54.83 ± 12.67 | 0.714 | 52.07 ± 7.73 | 55.56 ± 14.05* | 0.041 |
| 48.74 ± 16.91 | 61.88 ± 19.41** | 0.001 | 50.62 ± 15.45 | 55.69 ± 20.23 | 0.079 | 47.84 ± 13.18 | 56.58 ± 20.38** | 0.001 | |
| RE | 33.33 ± 45.93 | 59.26 ± 47.87** | 0.001 | 37.42 ± 26.96 | 46.88 ± 24.82 | 0.241 | 31.16 ± 9.68 | 48.94 ± 28.93* | 0.027 |
| SF | 53.00 ± 21.12 | 58.67 ± 21.21** | 0.001 | 53.74 ± 22.14 | 61.88 ± 22.27* | 0.032 | 53.38 ± 17.47 | 61.82 ± 23.71* | 0.013 |
| MH | 57.08 ± 11.95 | 61.33 ± 12.12** | 0.023 | 58.86 ± 10.83 | 58.86 ± 12.71 | 0.998 | 55.83 ± 9.76 | 59.97 ± 12.79* | 0.048 |
| VT | 51.55 ± 11.58 | 58.26 ± 13.97** | 0.001 | 52.45 ± 10.16 | 55.12 ± 13.97 | 0.167 | 50.98 ± 6.72 | 55.60 ± 14.50** | 0.005 |
| 57.61 ± 12.70 | 61.03 ± 10.60 | 0.057 | 60.69 ± 10.03 | 58.38 ± 12.61 | 0.209 | 55.87 ± 12.84 | 60.20 ± 11.45* | 0.035 | |
*p < 0.05, **p < 0.01.
Variables of the study during the pandemic (n = 172).
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ||||||||||
| 2.PF | 0.799** | 1 | ||||||||
| 3.RP | 0.786** | 0.493** | 1 | |||||||
| 4.BP | 0.619** | 0.318** | 0.191* | 1 | ||||||
| 5.GH | 0.512** | 0.293** | 0.265** | 0.283** | 1 | |||||
| 0.609** | 0.288** | 0.471** | 0.525** | 0.499** | 1 | |||||
| 7.RE | 0.530** | 0.213** | 0.503** | 0.440** | 0.294** | 0.901** | 1 | |||
| 8.SF | 0.465** | 0.272** | 0.243** | 0.461** | 0.461** | 0.733** | 0.446** | 1 | ||
| 9.MH | 0.358** | 0.164* | 0.221** | 0.321** | 0.440** | 0.674** | 0.485** | 0.415** | 1 | |
| 10.VT | 0.464** | 0. 272** | 0.265** | 0.346** | 0.633** | 0.624** | 0.345** | 0.526** | 0.504** | 1 |
| 0.309** | 0.184* | 0.195* | 0.207** | 0.411** | 0.407** | 0.338** | 0.263** | 0.364** | 0.338** |
*p < 0.05, **p < 0.01.
Hierarchical multiple regression of PCS and MCS during the pandemic (n = 172).
| Step 1( | Step 2( | Step 3( | Step 1( | Step 2( | Step 3( | ||
|---|---|---|---|---|---|---|---|
| Age | − 0.118 | − 0.110 | − 0.113* | − 0.174* | − 0.137 | − 0.141* | |
| Gender | (Male vs. Female) | 0.016 | − 0.020 | − 0.020 | 0.001 | − 0.064 | − 0.065 |
| Marital status | (Married vs. Other) | − 0.012 | − 0.048 | − 0.055 | − 0.035 | − 0.094 | − 0.110 |
| Education level | (High school or above vs. Junior school or under) | − 0.001 | 0.033 | 0.016 | − 0.068 | − 0.024 | − 0.059 |
| Monthly income | (≤ 3000 vs. 3000–6000) | 0.024 | 0.009 | 0.010 | 0.090 | 0.041 | 0.044 |
| (≤ 3000 vs. > 6000) | − 0.007 | 0.012 | − 0.011 | − 0.003 | 0.014 | − 0.036 | |
| Chronic diseases | (> 3 vs. ≤ 2) | − 0.126* | − 0.135* | − 0.131* | − 0.044 | − 0.048 | − 0.039 |
| ADL | − 0.589** | − 0.606** | − 0.587** | − 0.123 | − 0.163 | − 0.122 | |
| Types of stroke | (Intracerebral hemorrhage vs. Cerebral infarction) | − 0.129 | − 0.109 | − 0.092 | − 0.190* | − 0.195* | − 0.159* |
| Hemiplegia | (Y vs. N) | − 0.136* | − 0.123* | − 0.109 | − 0.131 | − 0.111 | − 0.080 |
| Aphasia | (Y vs. N) | 0.021 | 0.039 | 0.039 | 0.028 | 0.052 | 0.051 |
| Dysphagia | (Y vs. N) | 0.036 | 0.020 | 0.018 | − 0.158* | − 0.143* | − 0.138* |
| Felt that the “impacts of the pandemic on daily life were high or very high” | (Y vs. N) | − 0.255** | − 0.231** | − 0.404** | − 0.353** | ||
| Felt that the “risks of contracting the COVID-19 were high or very high” | (Y vs. N) | − 0.084 | − 0.055 | − 0.271** | − 0.208** | ||
| Felt that “worries about the pandemic were high or very high” | (Y vs. N) | 0.006 | 0.044 | − 0.208** | − 0.124 | ||
| 0.129* | 0.284** | ||||||
| 1.817 | 1.590 | 1.403 | 2.125 | 2.833 | 2.489 | ||
| Adjusted R2 | 0.474** | 0.557** | 0.568** | 0.066 | 0.303** | 0.369** | |
| △R2 | 0.474 | 0.083 | 0.011 | 0.066 | 0.237 | 0.066 | |
Adjusted R2: A changed variation of R2 that has been changed for the number of variables. The adjusted R2 rises when the model improves with new blocks of variables; ΔR2:An index for measuring the proportion of the variability of the single variable or block that is explained by the models; β: the partial regression coefficient of the variables, which indicates the amount by which the dependent variable increases or decreases for each change of a specified independent variable by a unit; Ɛ: Constant; *p < 0.05, **p < 0.01.
Figure 2Forest plot of PCS.
Figure 3Forest plot of MCS.
Figure 4Variables associated with stroke patients’ QOL during the COVID-19 pandemic.